Publicaciones (20) Publicaciones en las que ha participado algún/a investigador/a

1994

  1. AAS formulations: Dissolution profile and gastrotoxicity

    Proceedings of the Controlled Release Society

  2. APLICACION DE LA CRONOFARMACOCINETICA A LA OPTIMIZACION DE LA FARMACOTERAPIA

    Anales de la Real Academia de Farmacia

  3. Análisis de distintos principios activos de interés en preparados farmacéuticos antiobesidad

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 3, pp. 65-67

  4. Comparison of assay methods by second-derivative spectroscopy, colorimetry and fluorescence spectroscopy of salicylic acid in aspirin preparations with a high-performance liquid chromatographic method

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 12, Núm. 3, pp. 383-387

  5. Cross antigenicity among ovine trichostrongyloidea. Preliminary report

    Veterinary Parasitology, Vol. 53, Núm. 3-4, pp. 243-251

  6. Dissolution efficiency and release kinetics of three diclofenac sodium controlled-release formulations

    S.T.P. Pharma Pratiques, Vol. 4, Núm. 2, pp. 108-115

  7. Dissolution study of spiramycin: influence of agitation intensity and addition of several substances to the dissolution medium

    International Journal of Pharmaceutics, Vol. 110, Núm. 3, pp. 223-229

  8. Effect of different excipients on the tableting of coated particles

    International Journal of Pharmaceutics, Vol. 106, Núm. 2, pp. 149-155

  9. Excreción renal de fármacos: mecanismos implicados

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 4, pp. 49-53

  10. In vitro drug release of flubendazole solid dispersions

    Proceedings of the Controlled Release Society

  11. Incremento del pH por antiácidos: influencia sobre la constante de velocidad de disolución en nuevas formalaciones de comprimidos obtenidas por compresión directa

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 5, pp. 85-88

  12. P271 influence of the excipient on the rheology and drug release of a topical formulation

    European Journal of Pharmaceutical Sciences, Vol. 2, Núm. 1-2, pp. 186

  13. Partial Protection of Manchego Sheep against Haemonchus contortus after a 6‐Month Postpriming Period. Preliminary Note

    Journal of Veterinary Medicine, Series B, Vol. 41, Núm. 1-10, pp. 399-406

  14. Pharmaceutical development of tablets of a new antineoplastic drug: mitonafide

    Pharmaceutica Acta Helvetiae, Vol. 69, Núm. 2, pp. 101-105

  15. Photolability evaluation of the new cytostatic drug mitonafide

    Arzneimittel-Forschung/Drug Research, Vol. 44, Núm. 1, pp. 81-83

  16. Polyamine content and drug sensitivities of different clonal lines of Leishmania infantum promastigotes

    Parasitology Research, Vol. 80, Núm. 3, pp. 203-207

  17. Preparation and evaluation of mequitazine/PEG 6000 binary systems

    Pharmazie, Vol. 49, Núm. 12, pp. 906-909

  18. Qualitative and quantitative determination of two new antitumor agents from 1-8 naphthalimides in tablets. Validation of a high performance liquid chromatography method

    Arzneimittel-Forschung/Drug Research, Vol. 44, Núm. 5, pp. 659-662

  19. Solid state interactions of two new antineoplastic drugs (mitonafide and amonafide) and common tablet excipients in preformulation studies

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 40, Núm. 1, pp. 41-43

  20. Solvent influence in EC-microcapsules formation

    Proceedings of the Controlled Release Society